Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Circ Cardiovasc Imaging. 2014 May;7(3):573. doi: 10.1161/CIRCIMAGING.114.001756

Response to Letter Regarding Article, “Transesophageal Echocardiography in Cryptogenic Stroke and Patent Foramen Ovale Analysis of Putative High-Risk Features From the Risk of Paradoxical Embolism Database”

Benjamin S Wessler 1, David E Thaler 2, Robin Ruthazer 3, Christian Weimar 4, Marco R Di Tullio 5, Mitchell S V Elkind 6, Shunichi Homma 5, Jennifer S Lutz 3, Jean-Louis Mas 7, Heinrich P Mattle 8, Bernhard Meier 9, Krassen Nedeltchev 10, Federica Papetti 11, Emanuele Di Angelantonio 12, Mark Reisman 13, Joaquín Serena 14, David M Kent 2,3
PMCID: PMC4090764  NIHMSID: NIHMS585565  PMID: 24847015

Dr. Schuchlenz makes important observations that help frame the conclusions we reached through analysis of the transesophageal echocardiography (TEE) data from the Risk of Paradoxical Embolism (RoPE) database, and appropriately highlights some of the limitations of this dataset. Specifically, important anatomic features (presence or absence of a prominent Eustachian Valve) were not routinely reported across the component databases. Additionally, microbubbles were routinely injected via the antecubital vein, a site that Dr. Schuchlenz correctly identifies as correlating less well with anatomic size.

To create our RoPE database,1 component studies were combined and data were harmonized with the goals of improving on the methodological and statistical limitations of small individual studies. Yet harmonization across databases creates its own challenges and necessarily excludes details that might not be uniformly collected across component studies, including some TEE variables. Our observation that proposed ‘high risk’ TEE features do not correlate with the significance of an observed PFO for patients with cryptogenic stroke2 should be viewed not as a failure of the imaging modality as ideally applied. Instead, we view it as a call for further refining the technique, improving standardization and conducting further research, and as a call too for development of complimentary techniques to better assess risk.

Acknowledgments

Sources of Funding

This study was partially funded by grants UL1 RR025752, R01 NS062153, and R21 NS079826, all from the National Institutes of Health.

Footnotes

Disclosures

Both David M. Kent and David E. Thaler have consulted for WL Gore Associates. David E. Thaler is a consultant to AGA Medical Corporation. There are no other conflicts of interest to disclose.

References

  • 1.Thaler DE, Di Angelantonio E, Di Tullio MR, Donovan JS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Ruthazer R, Serena J, Weimar C, Elkind MS, Kent DM. The Risk of Paradoxical Embolism (RoPE) Study: initial description of the completed database. Int J Stroke. 2013;8:612–619. doi: 10.1111/j.1747-4949.2012.00843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging. 2014;7:125–131. doi: 10.1161/CIRCIMAGING.113.000807. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES